Ultrasound-measured enlargement of the cross-sectional area of the median nerve as a marker for early neuronal lesions in pediatric type 1 diabetes

Résumé fourni par la source

Diabetic neuropathy can develop early in type 1 diabetes (T1D), but reliable non-invasive markers for subclinical nerve damage due to metabolic alterations in children and adolescents are lacking. We conducted a controlled cross-sectional study of 73 patients with T1D (8-16 years, diabetes duration > 6 months) and 71 age-matched controls to identify abnormalities of the median nerve using high-resolution ultrasound. Cross-sectional area (CSA) of the median nerve was measured at the wrist and mid-forearm and related to body surface area (BSA) and glycemic control (HbA1c) using linear regression models. CSA at the wrist did not differ between groups, whereas CSA at the mid-forearm was higher in children with T1D reaching statistical significance in those with HbA1c > 9%. Although CSA correlated positively with BSA across all participants, in patients with T1D, it remained significantly associated with HbA1c after adjustment for BSA (regression coefficient 0.217 mm² per % HbA1c [95% CI 0.073-0.361], p = 0.004; for BSA: 4.226 mm² per m² [95% CI 2.899-5.554], p < 0.001), even in those with diabetes duration of less than 2 years. These findings indicate that, despite normal examination, ultrasound can detect enlargement of the median nerve in pediatric T1D, which is associated with poor metabolic control.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.